找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Current and Future Immunosuppressive Therapies Following Transplantation; Mohamed H. Sayegh,Giuseppe Remuzzi Book 2001 Springer Science+Bu

[復(fù)制鏈接]
樓主: 教條
51#
發(fā)表于 2025-3-30 08:58:23 | 只看該作者
52#
發(fā)表于 2025-3-30 13:51:56 | 只看該作者
53#
發(fā)表于 2025-3-30 18:31:16 | 只看該作者
Clinical Trials in Transplant Immunosuppression: What Have We Learned?sease. Randomization minimizes selection bias and prevents bias in the comparison between study groups due to regression toward the mean. However, there is no guarantee that bias is entirely eliminated even in a prospective study with double blinding.
54#
發(fā)表于 2025-3-30 23:31:22 | 只看該作者
Use of Corticosteroids in Kidney Transplantionllograft rejection was first reported in the early 1960s [2],[3]. Thereafter, combination of azathioprine and steroids became the conventional maintenance immunosuppression regimen in organ transplantation and remained so for almost two decades.
55#
發(fā)表于 2025-3-31 02:16:21 | 只看該作者
Mycophenolate Mofetil and Azathioprined trials that mycophenolate mofetil (MMF) had better efficacy for the prevention of acute rejection following renal transplantation [3–5]. Although MMF has replaced azathioprine in chronic immunosuppression protocols, many centers still use azathioprine, particularly in low-risk patients.
56#
發(fā)表于 2025-3-31 06:18:51 | 只看該作者
Monoclonal Antibody Targeting of the T Cell Receptor Complex81, few years before it could be firmly established that the specific molecular target of OKT3 was one of the polypeptide chains included within the major T cell recognition element namely, the T cell antigen receptor (TCR)/CD3 complex.
57#
發(fā)表于 2025-3-31 12:09:06 | 只看該作者
Book 2001 the basic science mechanisms andclinical applicability of these strategies. The uniqueness of thisbook is the inclusion of up-to-date information on the basicmechanisms of actions of the immunosuppressive drugs as well as asummary of the clinical trials data and the potential use of thesedrugs in c
58#
發(fā)表于 2025-3-31 13:59:05 | 只看該作者
59#
發(fā)表于 2025-3-31 20:33:37 | 只看該作者
Clinical Trials in Transplant Immunosuppression: What Have We Learned?e. The experimental design most appropriate for the comparison of therapeutic intervention is the randomized controlled clinical trial. These trials are designed to assess the efficacy of treatment in quantitative terms which are frequency of defined events (primary end-points) and time course of di
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-29 20:48
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
临颍县| 额敏县| 红河县| 濮阳市| 托里县| 庆元县| 云林县| 苗栗市| 寿阳县| 兰溪市| 吉林市| 左贡县| 卢湾区| 武强县| 兴和县| 阜康市| 靖安县| 宣武区| 西昌市| 定兴县| 革吉县| 涟水县| 江西省| 台州市| 永胜县| 扎赉特旗| 琼中| 兴和县| 奈曼旗| 定陶县| 清新县| 申扎县| 屏边| 两当县| 建湖县| 平阳县| 察雅县| 静宁县| 娄烦县| 光泽县| 汉寿县|